Kromek Share Discussion Threads

[charlie_bucket] 27/1/2022 14:24

As a counterweight to the optimism from AQC888 and others:

A concern of mine is that the company is looking for a short term boost to the share price before announcing a placing / cash raise again soon. Particularly helpful if the share price rises on the back of another Simon Thompson recommendation. This is still very much a loss making company which will need future cash raises – despite talk of “cash profit” or “Adjusted EBITDA” – since revenue isn’t high enough yet to break even, plus development costs go to the balance sheet and don’t get deducted until later in the P&L.

For last 6 months just published, loss before tax was £3.1m but that’s after forgiveness of COVID loans (£1.3m) and £3.1m of R&D costs capitalized which was higher than the R&D cost amortization (£1.0m). If my thinking here is correct, that makes £6.5m underlying cash outflow (excl. tax) for a half year. They had cash balance of £10.2m end of October minus £4.8m short term borrowings, so £5.4m net cash.

Timing of placing announcement last year was 12th February, and share price fell about 15% on day of announcement. Now could be the time of year that they think about another one.

[strategicinvestor2] 26/1/2022 12:17

Not sure what market and shares Ark has even watching the last few days - hopefully he lifts his head out of the sands some month soon …..

[b00mb0y] 25/1/2022 20:31

BA.2: New omicron sub-variant could prolong UK epidemic, warn experts

[strategicinvestor2] 25/1/2022 19:44

Market has been very strong and bounced back today …..

[ark87] 25/1/2022 18:59

strategicinvestor2 - Don't think i seen you get a prediction right yet. Hopefully you turn bearish soon.

[aqc888] 25/1/2022 18:57

I think Simon Thompson’s annual choice for shares for 2022 are out next Friday. Kromek is definitely a strong contender, I’d give it a 50% chance of appearing on it. Will gain 10-40% on the day if it makes it. If not biological pathogen news should available by April and the nuclear detector tenders results should be revealed too in the near future. Then there’s the wildcard of a bid for the CZT business following Kromek stating they are prepared to sell this. Canon paid 200m for a similar business recently. An exciting few months.

[strategicinvestor2] 24/1/2022 22:33

I suspect market and Kromek will increase strongly tomorrow Imho DYOR

[abbynat] 24/1/2022 21:32

pity, kromek was in an upward steady rise until the global rot appeared.
wonder if this will last days or heaven forbid weeks!

[b00mb0y] 24/1/2022 16:01

Always a sad excuse when it drops!

[aqc888] 24/1/2022 14:28

Kromek losing just 2.5% makes it one of the winners today! Some huge losses in tech companies, luckily I sold all my augmentum fintech shares last month

[aqc888] 21/1/2022 22:10

“ Investors turn to Europe in search of stock market bargains” headline on FT. Hopefully a dollar or two comes Kromeks way!

[ark87] 21/1/2022 18:17

The fact we are green on a panic day for market can only be a good sign for next week.

[aqc888] 20/1/2022 11:47

I didn’t think you could Quepassa. No point in engaging with you. You’re here with some pathetic vendetta because you invested with ‘a significant stake’ in Kromek at the beginning of this thread 8years ago.

(Thread number 37. November 2013.)

[quepassa] 20/1/2022 11:24

Post 5235 refers.



NOTA BENE AQ's words:- "I'M JUST WAITING FOR THE CHANCE TO EXIT".

[aqc888] 20/1/2022 11:08

Quepassa, look at the x3 triggers of significant share price gains I identified above and dissect each one for me to explain why it won’t happen. So far your advice hasn’t been too good... share price dire and heading down at 13.5p... tipsters won’t touch Kromek with a barge pole (an hour before Simon Thompson tipped Kromek)... but I’d like to hear your detailed explanation as to why each of the three events won’t happen

[estienne] 20/1/2022 09:32

People get hooked on tipsters. I tracked a number of Simon Thompson's tips and they're all well down

[quepassa] 20/1/2022 09:05

Whatever spin anyone tries to put on it, Kromek hasn't yet managed to commercialise the pathogen detector and - let's face it- the half-year results were pretty terrible.

It amazes me that yet again they have managed to distract everybody's attention away from the hard results and onto promises of wonderful things tomorrow.

And if they hadn't received forgivenness on the $1.8m PPP loans from Uncle Sam ( classed as Other Income), the results would have been a shocker.

ALL IMO. DYOR.
QP

[strategicinvestor2] 20/1/2022 08:52

Can see strong demand here with share price back to over 20p in coming days hopefully IMHO DYOR

[aqc888] 19/1/2022 17:49

Personally I’m excited. I see x3 triggers that are all pretty likely to happen in the near future. Nuclear tenders, biological pathogen sales and divestment of part of business. If any one of these happens Kromeks £60m market cap could multiply by 2-20 times. X2 being successful nuclear detector tender and x20 for a biological pathogen detector sale to a government or two. KAPscan was trademarked in the us last month where the us Congress were pushing for $10billion a year for x10 years budget for bio defences. They also are looking for x3 separate systems to work in tandem. Considering there are so few players here and Kromek have US factories I’d say this wasn’t such an outlandish proposition. Especially since Kromek had a 2year head start and have been patenting prolifically making it 4th on the ip100 U.K. list. A us government order would make my x20 multiple of Kromeks share price look very conservative. Let alone all the other governments around the world. One analyst puts the global market at £500m last year with Kromek gaining 20%. Then there’s the sale of part of the business which could multiple the share price by x4 given the recent sale price of the only rival.

Need to look at the details of Kromek. Looking at the past might not be an accurate guide to the future on this one. Kromek also has a very good chance of making it on Simon Thompson bargain shares list. Which would add 20% next month. Last year my largest invest was in Duke Royalty which firstly made it on his list and secondly was the best performer on it. This year Kromek has taken the place of largest exposure to a single company and I’m increasingly confident that it will be a star performer of 2022

[simithy] 19/1/2022 16:59

Just clicked on for a pathogen detector update. Wondered if the issues of specificity had been circumvented, or what?

Didn’t see a role for nanopore technology in the Covid space - if that was the plan but happy to learn otherwise - although the moment is probably gone. H5N7 flu community spreading would be devastating- near 100% mortality rates if human-human transfer establishes.

Radiation detection might be the way forward when it kicks off with Putin.
God forbid.

IMO

[talk2tony] 19/1/2022 16:58

Doubled my stake after hearing comments from ST, especially the probability of some pathogen detector orders in April. One other point is that I think in the past Kromek did all/most of the manufacturing in house but by outsourcing this could mean an expectation of a large ramp up in demand and thus production due to the detector.

Doe anyone have any idea if the detector will be direct sales or perhaps a service agreement which would include machine repair/servicing and restocking of reagents (from their literature they would need changing every day) and even perhaps analysis. This would help with recurring income. Even if a direct sale they would probably have exclusive agreement on reagents.

The NHS deal could be the gamechanger and lead to mores sales abroad. It will be interesting to see not only how these machines are rolled out but the protocols based on positive detection. This, in my view, will be vital to the future success of the product.

[sphere25] 19/1/2022 16:03

Entering Jam City, neighbour to PuntVille.

Been a while since visiting KMK.

It is still a trading share with some lovely spikes to ride out in the past. They appear to be delivering abit of the jam but the market isn't buying it. Looking at that ST article, that is about as bullish an article as you can put out.

I mean wow! That is proper fruity filled jam! You can almost smell it from here.

Judging by the movement today, it looks like at least one buyer in size has put an order in with the market makers to grab x amount at these levels, but no idea how big and clearly little movement in the price suggests nothing significant of note yet.

I think it is always worth keeping an eye on these sorts just to see if anyone does come in for some whoppers to piggy back as a momentum play.

They have been give a rather large dollop there to think about.

Waiting and watching but not keen on the room rates in Jam City.

All imo
DYOR